367 related articles for article (PubMed ID: 26088962)
1. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
2. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
[TBL] [Abstract][Full Text] [Related]
3. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
4. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
[TBL] [Abstract][Full Text] [Related]
5. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
[TBL] [Abstract][Full Text] [Related]
7. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
8. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
Yu CC; Liao YW; Yu CH; Chang YC
J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
[TBL] [Abstract][Full Text] [Related]
9. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
[TBL] [Abstract][Full Text] [Related]
10. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
11. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
12. Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
Lin CY; Hsieh PL; Liao YW; Peng CY; Yu CC; Lu MY
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884781
[TBL] [Abstract][Full Text] [Related]
13. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis--a precancer condition.
Chang MC; Lin LD; Wu HL; Ho YS; Hsien HC; Wang TM; Jeng PY; Cheng RH; Hahn LJ; Jeng JH
Carcinogenesis; 2013 May; 34(5):1096-104. PubMed ID: 23349021
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
15. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
17. E3 ligase carboxyl-terminus of Hsp70-interacting protein (CHIP) suppresses fibrotic properties in oral mucosa.
Chen SC; Liu CM; Hsieh PL; Liao YW; Lin YJ; Yu CC; Yu CH
J Formos Med Assoc; 2020 Feb; 119(2):595-600. PubMed ID: 31653576
[TBL] [Abstract][Full Text] [Related]
18. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
[TBL] [Abstract][Full Text] [Related]
19. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
20. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
Yang SF; Hsieh YS; Tsai CH; Chou MY; Chang YC
Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
